147 related articles for article (PubMed ID: 9781641)
1. Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology.
Sloane JP; Amendoeira I; Apostolikas N; Bellocq JP; Bianchi S; Boecker W; Bussolati G; Coleman D; Connolly CE; Dervan P; Eusebi V; De Miguel C; Drijkoningen M; Elston CW; Faverley D; Gad A; Jacquemier J; Lacerda M; Martinez-Penuela J; Munt C; Peterse JL; Rank F; Sylvan M; Tsakraklides V; Zafrani B
Hum Pathol; 1998 Oct; 29(10):1056-62. PubMed ID: 9781641
[TBL] [Abstract][Full Text] [Related]
2. Pathologists' agreement with experts and reproducibility of breast ductal carcinoma-in-situ classification schemes.
Wells WA; Carney PA; Eliassen MS; Grove MR; Tosteson AN
Am J Surg Pathol; 2000 May; 24(5):651-9. PubMed ID: 10800983
[TBL] [Abstract][Full Text] [Related]
3. Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: a comparative study with long follow-up.
Badve S; A'Hern RP; Ward AM; Millis RR; Pinder SE; Ellis IO; Gusterson BA; Sloane JP
Hum Pathol; 1998 Sep; 29(9):915-23. PubMed ID: 9744307
[TBL] [Abstract][Full Text] [Related]
4. Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression.
Poller DN; Silverstein MJ; Galea M; Locker AP; Elston CW; Blamey RW; Ellis IO
Mod Pathol; 1994 Feb; 7(2):257-62. PubMed ID: 7911998
[TBL] [Abstract][Full Text] [Related]
5. Prognostic classification of breast ductal carcinoma-in-situ.
Silverstein MJ; Poller DN; Waisman JR; Colburn WJ; Barth A; Gierson ED; Lewinsky B; Gamagami P; Slamon DJ
Lancet; 1995 May; 345(8958):1154-7. PubMed ID: 7723550
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast.
Bethwaite P; Smith N; Delahunt B; Kenwright D
J Clin Pathol; 1998 Jun; 51(6):450-4. PubMed ID: 9771444
[TBL] [Abstract][Full Text] [Related]
7. A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma.
Douglas-Jones AG; Gupta SK; Attanoos RL; Morgan JM; Mansel RE
Histopathology; 1996 Nov; 29(5):397-409. PubMed ID: 8951484
[TBL] [Abstract][Full Text] [Related]
8. Ductal carcinoma in situ of the breast: reproducibility of histological subtype analysis.
Scott MA; Lagios MD; Axelsson K; Rogers LW; Anderson TJ; Page DL
Hum Pathol; 1997 Aug; 28(8):967-73. PubMed ID: 9269834
[TBL] [Abstract][Full Text] [Related]
9. The clinical behavior of breast carcinoma is probably determined at the preinvasive stage (ductal carcinoma in situ).
Gupta SK; Douglas-Jones AG; Fenn N; Morgan JM; Mansel RE
Cancer; 1997 Nov; 80(9):1740-5. PubMed ID: 9351542
[TBL] [Abstract][Full Text] [Related]
10. Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology.
Elston CW; Sloane JP; Amendoeira I; Apostolikas N; Bellocq JP; Bianchi S; Boecker W; Bussolati G; Coleman D; Connolly CE; Dervan P; Drijkoningen M; Eusebi V; Faverly D; Holland R; Jacquemier J; Lacerda M; Martinez-Penuela J; de Miguel C; Mossi S; Munt C; Peterse JL; Rank F; Reiner A; Sylvan M; Wells CA; Zafrani B
Eur J Cancer; 2000 Sep; 36(14):1769-72. PubMed ID: 10974624
[TBL] [Abstract][Full Text] [Related]
11. [Ductal hyperplasia and ductal carcinoma in situ. Definition--classification--differential diagnosis].
Böcker W; Decker T; Ruhnke M; Schneider W
Pathologe; 1997 Jan; 18(1):3-18. PubMed ID: 9157402
[TBL] [Abstract][Full Text] [Related]
12. Is the appearance of microcalcifications on mammography useful in predicting histological grade of malignancy in ductal cancer in situ?
Dinkel HP; Gassel AM; Tschammler A
Br J Radiol; 2000 Sep; 73(873):938-44. PubMed ID: 11064645
[TBL] [Abstract][Full Text] [Related]
13. Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology.
Sloane JP; Amendoeira I; Apostolikas N; Bellocq JP; Bianchi S; Boecker W; Bussolati G; Coleman D; Connolly CE; Eusebi V; De Miguel C; Dervan P; Drijkoningen R; Elston CW; Faverly D; Gad A; Jacquemier J; Lacerda M; Martinez-Penuela J; Munt C; Peterse JL; Rank F; Sylvan M; Tsakraklides V; Zafrani B
Virchows Arch; 1999 Jan; 434(1):3-10. PubMed ID: 10071228
[TBL] [Abstract][Full Text] [Related]
14. Assessment of necrosis and hypoxia in ductal carcinoma in situ of the breast: basis for a new classification.
Bussolati G; Bongiovanni M; Cassoni P; Sapino A
Virchows Arch; 2000 Oct; 437(4):360-4. PubMed ID: 11097360
[TBL] [Abstract][Full Text] [Related]
15. Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast.
Douglas-Jones AG; Morgan JM; Appleton MA; Attanoos RL; Caslin A; Champ CS; Cotter M; Dallimore NS; Dawson A; Fortt RW; Griffiths AP; Hughes M; Kitching PA; O'Brien C; Rashid AM; Stock D; Verghese A; Williams DW; Williams NW; Williams S
J Clin Pathol; 2000 Aug; 53(8):596-602. PubMed ID: 11002762
[TBL] [Abstract][Full Text] [Related]
16. Classification of duct carcinoma in situ (DCIS) with a characterization of high grade lesions: defining cohorts for chemoprevention trials.
Lagios MD
J Cell Biochem Suppl; 1996; 25():108-11. PubMed ID: 9027606
[TBL] [Abstract][Full Text] [Related]
17. A proposal for the histopathological diagnosis of ductal carcinoma in situ of the breast.
Moriya T; Kasami M; Akiyama F; Ichihara S; Kurosumi M; Tsuda H; Umemura S; Akashi-Tanaka S; Imamura H; Iwase H; Shin E; Harada Y; Mitsuyama S; Ohuchi N
Breast Cancer; 2000; 7(4):321-5. PubMed ID: 11114858
[TBL] [Abstract][Full Text] [Related]
18. Cytological and architectural heterogeneity in ductal carcinoma in situ of the breast.
Quinn CM; Ostrowski JL
J Clin Pathol; 1997 Jul; 50(7):596-9. PubMed ID: 9306942
[TBL] [Abstract][Full Text] [Related]
19. Correlation between type and grade of ductal carcinoma in situ and concomitant invasive ductal carcinoma of the breast.
Rudnicka L; Stachura J
Pol J Pathol; 2000; 51(3):137-43. PubMed ID: 11247396
[TBL] [Abstract][Full Text] [Related]
20. p53, ErbB2, and TAG-72 expression in the spectrum of ductal carcinoma in situ of the breast classified by the Van Nuys system.
Kanthan R; Xiang J; Magliocco AM
Arch Pathol Lab Med; 2000 Feb; 124(2):234-9. PubMed ID: 10656732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
